SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Novo Nordisk shares fall nearly 2% after two trial cancellations

Novo Nordisk stock traded at $46.60 Monday, down nearly 2%, after

NOVOBNVO

60 on Monday, down nearly 2%, after